379 related articles for article (PubMed ID: 21666472)
1. Some observations on prope tolerance.
Calne R; Watson CJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
[TBL] [Abstract][Full Text] [Related]
2. Prope tolerance--the future of organ transplantation from the laboratory to the clinic.
Calne RY
Transpl Immunol; 2004; 13(2):83-6. PubMed ID: 15380538
[TBL] [Abstract][Full Text] [Related]
3. The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.
Agarwal A; Shen LY; Kirk AD
Transpl Immunol; 2008 Nov; 20(1-2):6-11. PubMed ID: 18824230
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of alemtuzumab in organ transplantation: current clinical status.
Ciancio G; Burke GW; Warque ME; Miller J
BioDrugs; 2006; 20(2):85-92. PubMed ID: 16626166
[TBL] [Abstract][Full Text] [Related]
5. Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation.
Weissenbacher A; Boesmueller C; Brandacher G; Oellinger R; Pratschke J; Schneeberger S
Immunotherapy; 2010 Nov; 2(6):783-90. PubMed ID: 21091110
[TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
Morales J; Bono MR; Fierro A; Iñiguez R; Zehnder C; Rosemblatt M; Calabran L; Herzog C; Benavente D; Aguiló J; Pefaur J; Alba A; Ferrario M; Simon W; Contreras L; Buckel E
Transplant Proc; 2008 Nov; 40(9):3223-8. PubMed ID: 19010240
[TBL] [Abstract][Full Text] [Related]
7. Alemtuzumab and liver transplantation: a review.
Dhesi S; Boland B; Colquhoun S
Curr Opin Organ Transplant; 2009 Jun; 14(3):245-9. PubMed ID: 19417659
[TBL] [Abstract][Full Text] [Related]
8. Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?
Zuber J; Hermine O; Chatenoud L; Legendre C
Curr Opin Organ Transplant; 2011 Dec; 16(6):606-13. PubMed ID: 21971509
[TBL] [Abstract][Full Text] [Related]
9. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
[TBL] [Abstract][Full Text] [Related]
11. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation.
Magliocca JF; Knechtle SJ
Transpl Int; 2006 Sep; 19(9):705-14. PubMed ID: 16918530
[TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells as a therapeutic tool to induce solid-organ transplant tolerance: current clinical experiences.
Nikoueinejad H; Sharif MR; Amirzargar A; Mirshafiey A; Einollahi B
Exp Clin Transplant; 2013 Oct; 11(5):379-87. PubMed ID: 23902519
[TBL] [Abstract][Full Text] [Related]
14. Tolerance induction.
Kupiec-Weglinski JW
Curr Opin Organ Transplant; 2008 Aug; 13(4):331-2. PubMed ID: 18685325
[No Abstract] [Full Text] [Related]
15. Campath induction for kidney transplantation: report of 297 cases.
Ortiz J; Palma-Vargas J; Wright F; Bingaman A; Agha I; Rosenblatt S; Foster P
Transplantation; 2008 Jun; 85(11):1550-6. PubMed ID: 18551058
[TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab (Campath-1H) in kidney transplantation.
Ciancio G; Burke GW
Am J Transplant; 2008 Jan; 8(1):15-20. PubMed ID: 18093269
[TBL] [Abstract][Full Text] [Related]
17. Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients.
Calne R; Moffatt SD; Friend PJ; Jamieson NV; Bradley JA; Hale G; Firth J; Bradley J; Smith KG; Waldmann H
Nihon Geka Gakkai Zasshi; 2000 Mar; 101(3):301-6. PubMed ID: 10773997
[TBL] [Abstract][Full Text] [Related]
18. Targeting T-cell memory: where do we stand?
Valujskikh A
Curr Opin Organ Transplant; 2008 Aug; 13(4):344-9. PubMed ID: 18685328
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulation and tolerance.
Knechtle SJ
Transplant Proc; 2010 Nov; 42(9 Suppl):S13-5. PubMed ID: 21095443
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of induction therapy with alemtuzumab in kidney transplantation: a meta-analysis.
Shou ZF; Zhou Q; Cai JR; Cheng J; He Q; Wu JY; Chen JH
Chin Med J (Engl); 2009 Jul; 122(14):1692-8. PubMed ID: 19719973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
